Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Dexcom Outlines Three-Pronged Growth Strategy To Reach $4-4.5BN Revenue Goal By 2025

Dec 11 2020

• By Marion Webb

Dexcom G7

Related Content

Abbott Surprises Analysts With CE Mark For Freestyle Libre 3

Sep 28 2020

Device Week, 10 December 2020 – LivaNova Divests Valves; Experts Address ‘Metabesity’

Dec 10 2020

Dexcom’s Q2 Earnings Exceed Wall Street Expectations; Holds G7 Launch

Jul 30 2020

Related Companies

DexCom, Inc.

Abbott

Terumo Corporation

Additional Topics

Growth Innovation Clinical Trials Companies Digital Health Research & Development Commercial Diabetic Care C-Suite Speaks Diagnostics Medical Device

More from Diabetic Care

More from Device Area

Twitter feed RSS feed RSS feed

About Us

About UsOpens in new window
Meet the Team
Advertise with us
Contact Us

Account

My Account
My View
Email Preferences
Start Free TrialOpens in new window

Publications

Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo

More

Medtech Top 100 Ranking
Data Trackers
FDA Warning Letters

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window